UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 123

Sortiert nach

Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety

Scientific reports, 2021-12, Vol.11 (1), p.24173-24173, Article 24173

2021

Volltextzugriff (PDF)

Common Genetic Variation within the Low-Density Lipoprotein Receptor-Related Protein 6 and Late-Onset Alzheimer's Disease

Proceedings of the National Academy of Sciences - PNAS, 2007-05, Vol.104 (22), p.9434-9439

2007

Volltextzugriff (PDF)

Facing depression with botulinum toxin: A randomized controlled trial

Journal of psychiatric research, 2012-05, Vol.46 (5), p.574-581

2012

Volltextzugriff (PDF)

Can Botulinum Toxin Help Patients With Borderline Personality Disorder?

The American journal of psychiatry, 2016-09, Vol.173 (9), p.940-941

2016

Volltextzugriff (PDF)

Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial

Journal of psychopharmacology (Oxford), 2022-02, Vol.36 (2), p.159-169

2022

Volltextzugriff (PDF)

Neuronal effects of glabellar botulinum toxin injections using a valenced inhibition task in borderline personality disorder

Scientific reports, 2022-08, Vol.12 (1), p.14197-11, Article 14197

2022

Volltextzugriff (PDF)

Interaction Between Behavioral Inhibition and Emotional Processing in Borderline Personality Disorder Using a Pictorial Emotional Go/No-Go Paradigm

Psychiatry research, 2017-10, Vol.256, p.286-289

2017

Volltextzugriff (PDF)

Botulinum toxin for depression: Does patient appearance matter?

Journal of the American Academy of Dermatology, 2016-01, Vol.74 (1), p.171-173.e1

2016

Volltextzugriff (PDF)

Agitation predicts response of depression to botulinum toxin treatment in a randomized controlled trial

Frontiers in psychiatry, 2014-03, Vol.5, p.36-36

2014

Volltextzugriff (PDF)

Cholesterol-related genes in Alzheimer's disease

Biochimica et biophysica acta, 2010-08, Vol.1801 (8), p.762-773

Wollmer, M. Axel

2010

Volltextzugriff (PDF)

Role for Glyoxalase I in Alzheimer's Disease

Proceedings of the National Academy of Sciences - PNAS, 2004-05, Vol.101 (20), p.7687-7692

2004

Volltextzugriff (PDF)

Botulinum toxin for the management of depression: An updated review of the evidence and meta-analysis

Journal of psychiatric research, 2021-03, Vol.135, p.332-340

2021

Volltextzugriff (PDF)

Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration

Neurobiology of aging, 2011-10, Vol.32 (10), p.1827-1838

2011

Volltextzugriff (PDF)

A functional genetic variation of the 5-HT2a receptor affects human memory

Nature neuroscience, 2003-11, Vol.6 (11), p.1141-1142

2003

Volltextzugriff (PDF)

Effects of glabellar botulinum toxin injections on resting-state functional connectivity in borderline personality disorder

European archives of psychiatry and clinical neuroscience, 2024-02, Vol.274 (1), p.97-107

2024

Volltextzugriff (PDF)

Vestibular stimulation on a motion-simulator impacts on mood States

Frontiers in psychology, 2012-01, Vol.3, p.499-499

2012

Volltextzugriff (PDF)

Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study

The journal of clinical psychiatry, 2014-08, Vol.75 (8), p.837

2014

Volltextzugriff (PDF)

The Use of Botulinum Toxin for Treatment of Depression

Botulinum Toxin Therapy, 2021, Vol.263, p.265-278

2021

Volltextzugriff (PDF)

Comment on effects of botulinum toxin type A on mood and cognitive function in patients with Parkinson's disease and depression

American journal of translational research, 2021-01, Vol.13 (9), p.10962-10963

2021

Volltextzugriff (PDF)

Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease

Neuron (Cambridge, Mass.), 2003-05, Vol.38 (4), p.547-554

2003

Volltextzugriff (PDF)

Ethnicity-dependent genetic association of ABCA2 with sporadic Alzheimer's disease

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2006-07, Vol.141B (5), p.534-536

2006

Volltextzugriff (PDF)

Common Kibra Alleles Are Associated with Human Memory Performance

Science (American Association for the Advancement of Science), 2006-10, Vol.314 (5798), p.475-478

2006

Volltextzugriff (PDF)

Depression – An emerging indication for botulinum toxin treatment

Toxicon (Oxford), 2015-12, Vol.107 (Pt A), p.154-157

2015

Volltextzugriff (PDF)

Passive Immunization against β-Amyloid Peptide Protects Central Nervous System (CNS) Neurons from Increased Vulnerability Associated with an Alzheimer’s Disease-causing Mutation

The Journal of biological chemistry, 2002-09, Vol.277 (36), p.33012-33017

2002

Volltextzugriff (PDF)

Memory clinics in Germany-structural requirements and areas of responsibility

Nervenarzt, 2021-07, Vol.92 (7), p.708-715

2021

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(102)
Buchkapitel
(19)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(116)
Japanisch
(8)
Deutsch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety

Common Genetic Variation within the Low-Density Lipoprotein Receptor-Related Protein 6 and Late-Onset Alzheimer's Disease

Facing depression with botulinum toxin: A randomized controlled trial

Can Botulinum Toxin Help Patients With Borderline Personality Disorder?

Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial

Neuronal effects of glabellar botulinum toxin injections using a valenced inhibition task in borderline personality disorder

Interaction Between Behavioral Inhibition and Emotional Processing in Borderline Personality Disorder Using a Pictorial Emotional Go/No-Go Paradigm

Botulinum toxin for depression: Does patient appearance matter?

Agitation predicts response of depression to botulinum toxin treatment in a randomized controlled trial

Cholesterol-related genes in Alzheimer's disease

Role for Glyoxalase I in Alzheimer's Disease

Botulinum toxin for the management of depression: An updated review of the evidence and meta-analysis

Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration

A functional genetic variation of the 5-HT2a receptor affects human memory

Effects of glabellar botulinum toxin injections on resting-state functional connectivity in borderline personality disorder

Vestibular stimulation on a motion-simulator impacts on mood States

Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study

The Use of Botulinum Toxin for Treatment of Depression

Comment on effects of botulinum toxin type A on mood and cognitive function in patients with Parkinson's disease and depression

Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease

Ethnicity-dependent genetic association of ABCA2 with sporadic Alzheimer's disease

Common Kibra Alleles Are Associated with Human Memory Performance

Depression – An emerging indication for botulinum toxin treatment

Passive Immunization against β-Amyloid Peptide Protects Central Nervous System (CNS) Neurons from Increased Vulnerability Associated with an Alzheimer’s Disease-causing Mutation

Memory clinics in Germany-structural requirements and areas of responsibility

Suchergebnisse filtern